Profitability Ratios
| Ratio |
Value |
| GP Margin |
81.9% |
| EBIT Margin |
24.0% |
| EBITDA Margin |
33.8% |
| Operating Margin |
23.4% |
| Pretax Margin |
21.1% |
| Cont. Ops Margin |
17.4% |
| Net Margin |
17.5% |
| Bottom Line Margin |
17.5% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
0.94 |
| Quick Ratio |
0.72 |
| Solvency Ratio |
0.245 |
| Cash Ratio |
0.19 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
0.29 |
| Forward PEG |
0.29 |
| Price/Book |
2.79 |
| Price/Sales |
2.32 |
| Price/FCF |
15.69 |
| Price/Op Cash Flow |
9.33 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.2604 |
| Debt/Equity |
0.6103 |
| Debt/Capital |
0.3790 |
| Long-Term Debt/Capital |
0.3368 |
| Financial Leverage |
2.34 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
-29.87 |
| Operating Cash Flow Ratio |
0.476 |
| Operating Cash Flow/Sales |
24.8% |
| Free Cash Flow/Operating Cash Flow |
59.5% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
3.62 |
| Interest Coverage |
8.1128 |
| Short-Term Operating Cash Flow Coverage |
4.58 |
| Operating Cash Flow Coverage |
0.49 |
| Capital Expenditure Coverage |
2.47 |
| Dividend + Capital Expenditure Coverage |
1.34 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
48.4739% |
| Dividend Yield |
3.6548% |
| Dividend Yield % |
3.6548% |
| Dividend Per Share |
6.4142 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
75.79 |
| EPS |
13.232 |
| Debt/Share |
40.5123 |
| Cash/Share |
7.41 |
| Book Value/Share |
62.86 |
| Tangible BV/Share |
-13.38 |
| Equity/Share |
62.80 |
| Operating Cash Flow/Share |
18.806 |
| Capital Expenditure/Share |
7.619 |
| FCF/Share |
11.187 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.827 |
| Earnings Before Tax/EBIT |
0.902 |
| Price/Fair Value |
2.79 |
| Debt/Market Cap |
0.2051 |
| Effective Tax Rate |
17.5% |
| Enterprise Value Multiple |
8.07 |
AZN - AstraZeneca PLC